 |
Mr. Glenn Saldanha |
| CEO & MD |
| |
|
| |
| |
 We have always worked towards growing our base business to a size and scale that enables us to fund our research activities, and we are close to realizing our aspirations...  read more |
| |
Innovation does not need and need not happen only in R&D. It should be all-pervasive. To put it simply, it is about creating something extra-ordinary from the ordinary...
read more |
| |
Today is a momentous day in the life of our organization – a day when we commit ourselves to an ideal that embodies our philosophy and vision for the future. Glenmark has always been recognized for a number of virtues, especially innovation and quality. And from now on it will also be known for paving a new way for a new world. A new way – our way – a way that will become our life and define how we do things in the new
world... read more |
|
| |
| In the span of a decade, we foresee the course of the global industry bifurcating into two business models - The Innovators : Who will invest into high-end discovery programs and earn a premium on proprietary molecules and 2. The Generic players who will market copies of off-patent molecules thereby catering to markets where healthcare costs are a rising concern... read more |
| |
| An organization as huge as ours cannot be controlled and managed by any group of individuals. It has to be managed by each of us and collectively only then can we build a stronger and better organization. We need to understand that our actions and inactions can have implications on the entire organization. All of us are goodwill ambassadors of the organization and we should do all in our power to protect and build the reputation of Glenmark.... read more |
